Originally published in Triangle Business Journal - May 4, 2012.

In the international business community, few law enforcement matters in recent years have attracted as much attention as the Foreign Corrupt Practices Act, FCPA enforcement - conducted by both the U.S. Department of Justice and the Securities and Exchange Commission - has been intense and increasing over the last decade. The total numbers of FCPA actions brought by both agencies have risen from a mere five in 2004 to between 40 and 74 in the last three years. This trend has particular relveance for Triangle companies, including pharmaceutical companies and clinical-research organizations.

Please see full article below for more information.